Arixtra
These highlights do not include all the information needed to use ARIXTRA safely and effectively. See full prescribing information for ARIXTRA. ARIXTRA (fondaparinux sodium injection), for subcutaneous useInitial U.S. Approval: 2001
d3b30c68-cf45-4b46-8ba6-72090f7ba01a
HUMAN PRESCRIPTION DRUG LABEL
Aug 20, 2020
Mylan Institutional LLC
DUNS: 790384502
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
fondaparinux sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
fondaparinux sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
fondaparinux sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
fondaparinux sodium
Product Details
FDA regulatory identification and product classification information